Emma Lorenzen, Ph.D. student, DVM

Chlamydia Vaccine Research, Department of Infectious Disease Immunology, Statens Serum Institut
Copenhagen Denmark

Any personal financial relationships? No

I will include, as the first slide of any presentation, a full disclosure of any financial relationships that may influence my presentation.

I agree to provide educational content and resources in advance for review if requested by ICMI.

To the best of my ability, I will ensure that any speakers or content I suggest is independent of commercial bias.

I will recuse myself from planning activity content in which I have a conflict of interest.

1. I will insure balance, independence, objectivity, and scientific rigor in my role in the planning, development or presentation of this CME activity.

2. I will comply with the requirements to protect health information under the Health Insurance Portability & Accountability Act of 1996 (HIPAA).

3. I will disclose any discussion or reference to unapproved or unlabeled uses of therapeutic agents or products.

4. I have input my full name below as attestation of agreement with declaration statements. Marking the check box and indicating my name is in lieu of signature and is considered an "e-signature".

Signed on 02/11/2015 by Emma Lorenzen

Papers:
T.126 Prime-Boost Immunization Strategy for Induction of local genital Immunity in the Minipig Model of Human Genital Chlamydia trachomatis Infection

	I will include, as the first slide of any presentation, a full disclosure of any financial relationships that may influence my presentation.
	I agree to provide educational content and resources in advance for review if requested by ICMI.
	To the best of my ability, I will ensure that any speakers or content I suggest is independent of commercial bias.
	I will recuse myself from planning activity content in which I have a conflict of interest.
	1. I will insure balance, independence, objectivity, and scientific rigor in my role in the planning, development or presentation of this CME activity.
	2. I will comply with the requirements to protect health information under the Health Insurance Portability & Accountability Act of 1996 (HIPAA).
	3. I will disclose any discussion or reference to unapproved or unlabeled uses of therapeutic agents or products.
	4. I have input my full name below as attestation of agreement with declaration statements. Marking the check box and indicating my name is in lieu of signature and is considered an "e-signature".